However, in HCC with CTNNB1 gene mutations, the recruitment of pro-inflammatory dendritic cells and, therefore, T cells to the tumor is abrogated by suppressing the production of chemokines CCL4 or CCL5 by tumor cells.67,68. The gene discussed is CTNNB1; the disease is neoplasm.